Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials / Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P.b., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S.c., Scalone, S., Marsico, V.a., Cardalesi, C., Cognetti, F., et al.. - In: GYNECOLOGIC ONCOLOGY. - ISSN 0090-8258. - 154:1(2019), pp. 83-88. [10.1016/j.ygyno.2019.04.012]
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials
Panici PB;Cognetti F;Schettino C;
2019
Abstract
Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.| File | Dimensione | Formato | |
|---|---|---|---|
|
Daniele_Prognostic-role_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
454.51 kB
Formato
Adobe PDF
|
454.51 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
